Results 61 to 70 of about 27,707 (119)

GLP-1 Receptor Agonist Coverage for Obesity in Medicaid and Total GLP-1 Receptor Agonist Utilization.

JAMA Health Forum
Khanna R, Wang MC, Venkataramani AS.
europepmc   +1 more source

Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis. [PDF]

Endocrine
Pisani D, Lorenza D, Fordellone M, Cerillo A, Fatigati M, Hanulíková P, Mariniello A, De Franciscis P, Pasquini L, La Verde M.   +9 more
europepmc   +1 more source

Integrating Precision Nutrition with GLP-1 Receptor Agonist Therapy: Mechanisms, Clinical Outcomes, and Pharmacoeconomic Implications. [PDF]

Pharmaceuticals (Basel)
Ruga S, Matarese E, Bava R, Lombardi C, Dimatteo T, Miscio L, Raponi M, Giordano A, Sansone C, Liguori G, Lombardi R.   +10 more
europepmc   +1 more source

Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP‑1 receptor agonist use. [PDF]

Curr Atheroscler Rep
Porterfield LR, Nadeem S, Swanson D, Hayek SS, Vaughan EM.   +4 more
europepmc   +1 more source

Exercise-induced anaphylaxis with a cofactor of GIP/GLP-1 receptor agonist: A case report. [PDF]

J Allergy Clin Immunol Glob
Chong AC, Elshaer A, Diaz-Menindez M, Squire JD, Wonnaparhown AM, Freeman CM.   +5 more
europepmc   +1 more source

Association of GLP-1 Receptor Agonist Prescriptions and Alcohol Consumption in the National Institutes of Health's All of Us Cohort. [PDF]

Alcohol Clin Exp Res (Hoboken)
Tyndall B, Gasdaska A, Brannock MD, Preble E, McPheeters M, Marcial L, Huda A, Egan J, Litwin TR, Adjemian J, Sastry C, Farokhnia M, Leggio L.   +12 more
europepmc   +1 more source

Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series. [PDF]

Case Rep Womens Health
Wong K, Al-Amri H, Werlang A.
europepmc   +1 more source

Comparative Positioning of Orforglipron Among Selected GLP-1 Receptor Agonist Benchmarks: A Narrative Review. [PDF]

Cureus
Castro-Gamboa J, Mora-Jiménez J, Arguedas-Chacón S, Zavaleta-Monestel E.   +3 more
europepmc   +1 more source

Editorial: Optimizing GLP-1 receptor agonist use: mechanisms, clinical applications, and safety profiles. [PDF]

Front Pharmacol
Rasineni K, Grigson PS.
europepmc   +1 more source

A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist. [PDF]

Front Pharmacol
Singh A, Shadangi S, Rana S.
europepmc   +1 more source